R&G PharmaStudies Co., Ltd. (SZSE: 301333)
Health Care · Life Sciences Tools & Services · CN
CN¥66.67
+3.70% today · +22.9% 1Y
R&G PharmaStudies Co., Ltd. (SZSE: 301333) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $952.14M.
Over the last twelve months the share price has gained 22.9%, trading between 43.79 and 91.78.
Tweenvest scores R&G PharmaStudies Co., Ltd. across four factors: quality 72/100, value 35/100, growth 52/100, dividend 7/100. Its strongest factor is quality.
301333 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $952.14M
- Revenue (TTM)
- $138.28M
- P/E
- 53.40
- EPS
- 1.25
- Dividend yield
- 0.24%
- Beta (5Y)
- 0.37
- 52-week high
- CN¥91.78
- 52-week low
- CN¥43.79
- Avg volume (3M)
- —
- Shares outstanding
- 95.80M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beijing Sun-Novo Pharmaceutical Research Co., Ltd.SHSE: 688621 | $1.16B | CN¥71.00 | -2.41% |
| Gerresheimer AGXTRA: GXI | $1.10B | €28.42 | -2.00% |
| PharmaResources (Shanghai) Co., Ltd.SZSE: 301230 | $1.03B | CN¥38.48 | +0.79% |
| Anhui Wanbang Pharmaceutical Technology Co.,Ltd.SZSE: 301520 | $982.60M | CN¥71.05 | -4.23% |
| Suven Life Sciences LimitedBSE: 530239 | $905.38M | Rs308.50 | -7.90% |
| Shanghai Runda Medical Technology Co., Ltd.SHSE: 603108 | $898.64M | CN¥9.97 | -0.10% |
| Cryoport, Inc.NasdaqCM: CYRX | $882.81M | $16.90 | -3.04% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $859.07M | CN¥9.53 | +2.47% |
Figures last refreshed Oct 4, 2026.